Skip to NavigationSkip to content

Pharmafile - Business Services News

Florida firm Catalyst Pharmaceuticals is suing the FDA after the agency approved a rival’s drug.
Swedish rare disease specialist Sobi has agreed to buy Swiss firm Novimmune ion a deal worth more than £400 million.
A California court has said Johnson & Johnson and Colgate-Palmolive must pay a total of nearly $10 million to a woman who developed cancer.
AstraZeneca’s new headquarters in Cambridge, United Kingdom are expected to cost more than double the sum of £330 million that the firm budgeted...
Vectura is on course for a new leader to take up the company’s reins after it was revealed that CEO James Ward-Lilley is to step down from his role...
French drugmaker Sanofi has revealed that its CEO Olivier Brandicourt is to retire from the role, to be replaced with Paul Hudson, CEO at...
Biogen's diroximel fumarate impresses at Phase 3 in relapsing multiple sclerosis; Pfizer supressed research suggesting arthritis drug Enbrel reduced...
The Department of Justice (DoJ) has filed new charges against Mallinckrodt alleging the Irish-listed firm illegally hiked the price of a vial of...
Patient centricity, derived from the NHS-driven thinking “no decision about me, without me,” has been adopted by pharma to understand their patients...
President Donald Trump has caused confusion as to whether or not the NHS will ‘be on the table’ in post-Brexit trade deal negotiations with the...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches